Vials of the Moderna Covid-19 vaccine. Guillaume Souvant/AFP via Getty Images Moderna shares plunged 12.3% in premarket trading on Thursday after sales of the company’s Covid-19 vaccine fell short of Wall Street analysts’ estimates by more than a billion dollars. The company reported total revenue of $5 billion for the third quarter of the year, […]
Read MoreYears ago, as I began my career as an investor, I read a book by Peter Lynch. Mr. Lynch had made his name, and his fortune, as the manager of Fidelity’s flagship Magellan fund in the late 70’s and ’80’s, and his incredible performance was one of the big reasons Magellan, at the time, was […]
Read MoreAs recently as a few months ago, a lot of signs about the global pandemic seemed to suggest that the worst of the worst was over, and we could all finally begin to put COVID-19 concerns and commentary in the rear view. As contagious variants of the virus have emerged, however, it has become more […]
Read MoreThroughout the past year and a half, stocks in the Health Care sector have drawn a lot of attention from investors and analysts. That includes stocks in the Pharmacy/Drugstore industry; these were names, like Walgreens Boots Alliance (WBA) and CVS Corporation (CVS) that worked actively in the early stages of the crisis to provide a […]
Read MoreEver since coronavirus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. Available vaccines are now available for distribution […]
Read MoreAs much as everybody is anxious to put the pandemic and COVID-19 concerns and commentary in the rear view, the practical reality is that the aftermath – which includes dealing with ongoing health concerns – will continue to extend through the rest of the year. In the United States, it’s tempting to say that the […]
Read MoreEver since coronavirus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. As of this writing, vaccinations have steadily […]
Read MoreBuy Price: $250.00 or better Sell Price: TradersPro Sell Signal Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company’s vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and […]
Read MoreThroughout the past year, stocks in the health care business have drawn a lot of attention from investors and analysts. That includes stocks in the Pharmacy/Drugstore industry; these were names, like Walgreens Boots Alliance (WBA)and CVS Corporation (CVS) that worked actively in the early stages of the crisis to provide a critical piece of the […]
Read MoreMoving deeper into 2021, more and more investors and analysts continue to attempt to look past the pandemic-driven pressures that have weighed on public activities and on the economy for the past year. One-year anniversaries are being marked, with the apparent assumption that with vaccines being administered on an accelerated basis and being made available […]
Read MoreIt is interesting to observe the distinction in performance between different sectors and industries, and their possible correlation to broader economic activity. One of the places where I think that can be seen more easily is in evaluating large-cap versus small-cap stocks. If you look at most of the biggest and most recognizable names in […]
Read MoreWhen economists and market analysts look back at the last year and talk about the most impactful trends that emerged as a result of the COVID-19 pandemic, the conversation inevitably steers towards remote work. Corporations around the world were forced to adjust their operational models in rapid fashion, sending large numbers of their workers to […]
Read MoreAs the pace and progress of vaccinations across the country, and the world begins to increase, more and more commentary is starting to talk in practical terms about concepts like “herd immunity,” when a large enough portion of the population has built antibodies either by recovery from coronavirus or through vaccination itself. Most of the […]
Read MoreFor more than a year, the Aerospace industry, which includes commercial airlines has been one of the biggest, unquestioned losers in the stock market. Yes, the biggest portion of that drop comes from the reality that the industry took some of the biggest drawdowns in the market starting in February 2020 as commercial travel dried […]
Read MoreI tend to take most of the information I get from news media with a large grain of salt. That is especially true of market media outlets, which have so much information to try to report about on a daily basis that they really can’t do much more than talk about whatever happens to be […]
Read More